Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2005 Nov;44(11):1277-8, 1280-6.
doi: 10.1007/s00120-005-0924-3.

[Selection criteria for the expected management of localised prostate cancer]

[Article in German]
M Graefen  1 , G Salomon, E Currlin, C Eichelberg, T Schlomm, H Huland
Affiliations
Review

[Selection criteria for the expected management of localised prostate cancer]

[Article in German]
M Graefen et al. Urologe A. 2005 Nov.

Abstract

Prostate cancer harbours the possibility of overtreatment more than any other malignant disease. Due to its slow growth, expected management is an established therapeutic option in newly diagnosed carcinomas. Improved diagnostic methods and the widespread use of PSA lead to earlier diagnosis of cancers that would not adversely affect the life expectancy of the patient, even when they were left untreated. Several statistical models have been published to identify such insignificant cancers; however, all such nomograms suffer from limited sensitivity and specificity. For the indication of expected management, comorbidity and life expectancy must be considered using risk scores and life tables. In general, expected management is a suitable option for elderly patients with low grade cancers. Young patients and those with intermediate or high-grade cancers are most likely to benefit from active local treatment.

PubMed Disclaimer

Similar articles

See all similar articles

Cited by

  • [Active surveillance for prostate cancer].
    Graefen M, Ahyai S, Heuer R, Salomon G, Schlomm T, Isbarn H, Budäus L, Heinzer H, Huland H. Graefen M, et al. Urologe A. 2008 Mar;47(3):261-9. doi: 10.1007/s00120-008-1638-0. Urologe A. 2008. PMID: 18273597 Review. German.

References

    1. JAMA. 2004 Jun 9;291(22):2713-9 - PubMed
    1. Oncology. 2004;67(3-4):194-202 - PubMed
    1. J Urol. 2004 Apr;171(4):1393-401 - PubMed
    1. J Urol. 2004 Mar;171(3):1111-6 - PubMed
    1. J Urol. 2005 Aug;174(2):553-6; discussion 556 - PubMed

LinkOut - more resources